AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edosat 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Saturn Formulations Pvt Ltd

Salt Composition

Edaravone (1.5mg)

Overview Edosat 1.5mg Injection

Neuro-protective Edostat 1.5mg Injection combats the debilitating effects of amyotrophic lateral sclerosis (ALS), a progressive neuromuscular disorder. Its antioxidant properties mitigate neuronal damage, helping to slow disease advancement. Administered intravenously by a healthcare professional, this injectable formulation is reserved for patients unable to take oral medication. Adhere strictly to your physician's prescribed dosage and schedule; if a dose is missed, administer it immediately upon recollection. Commonly reported side effects include headache, ecchymosis, and impaired gait. Transient injection site reactions (pain, erythema, edema) may occur but usually abate spontaneously. Persistent or troublesome side effects warrant medical consultation. Seek immediate medical help for any allergic response, such as pruritus, facial or lingual swelling.

Primary Ingredients of Edosat 1.5mg Injection

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Edosat 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edosat 1.5mg Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Edosat 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edosat 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Edosat 1.5mg Injection works:

Edosat 1.5mg Injection, a neuroprotective antioxidant, exhibits nootropic effects. Its mechanism involves mitigating neuronal damage from free radical attack, thereby slowing ALS symptom advancement. This benefit stems from its ability to restore the brain's antioxidant-oxidant balance, reducing oxidative stress.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edosat 1.5mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Edosat 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Edosat 1.5mg Injection with breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Edosat 1.5mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding the administration of Edosat 1.5mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.

LiverLiverCAUTION

For individuals with severe hepatic impairment, administering Edosat 1.5mg Injection requires careful consideration and potential dosage modification. Guidance from a physician is recommended. Data regarding Edosat 1.5mg Injection use in such patients is limited. Dosage alterations are not typically advised for those with mild to moderate liver disease.

What if you forget to take Edosat 1.5mg Injection :

NA

Facts to Know About Edosat 1.5mg Injection

LabelValue
Chemical Type Pyrazolone Derivative
Developing Habits No.
Type of Therapy Central Nervous System (CNS) Neurology
Action Class Cognitive enhancer

FAQs on Edosat 1.5mg Injection

Edosat 1.5mg Injection may cause confusion, headache, and gait disturbances. Less common side effects include skin rash and itching, breathing problems (shortness of breath, chest tightness, wheezing, cough, particularly in asthmatics), and fungal infections.
Edosat 1.5mg Injection, a liquid solution, is administered intravenously over one hour by a healthcare professional in a clinical setting. Initially, it's given daily for the first 14 days of a 28-day cycle. Subsequent cycles typically involve daily injections for the first 10 days of a 28-day cycle. Dosage frequency is determined by your doctor based on your individual response.
Edosat 1.5mg Injection treats amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease causing muscle weakness and atrophy due to nerve cell death. It achieves this by slowing the progression of nerve damage, thereby mitigating ALS symptom severity.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, other medications, or any Edosat 1.5mg Injection ingredient. Before starting edaravone, disclose all medications, vitamins, and supplements you're taking or plan to take; dosage adjustments or monitoring may be necessary. Inform your doctor about any history of asthma, or if you're pregnant, breastfeeding, or planning pregnancy. Contact your doctor immediately if you conceive while using edaravone.
While the preventability of ALS remains unproven due to a lack of supporting studies, mitigating risk factors may lessen the likelihood of developing the disease. These factors include smoking and exposure to pesticides and insecticides. Military service has also been identified as a potential risk factor in some reports.
People of Caucasian and non-Hispanic descent have the highest incidence of amyotrophic lateral sclerosis (ALS). Between 5% and 10% of ALS cases are inherited. Onset can occur at any age, though symptoms typically appear between ages 55 and 75. Men are slightly more prone to developing ALS than women, a difference that lessens with age. Research indicates military veterans may face a 1.5 to 2 times greater risk due to potential wartime toxin exposure.
Exposure to toxins during combat or intense physical exertion may heighten the risk of ALS in veterans and athletes, researchers propose.
ALS often begins with subtle muscle issues: twitches in the limbs or tongue, cramps, stiffness, and weakness in an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and chewing or swallowing difficult. Many first notice hand or arm weakness, struggling with tasks like buttoning a shirt or turning a key. Alternatively, leg weakness can be the initial symptom, causing tripping, stumbling, or difficulty with walking or running.
Edosat 1.5mg Injection
403
MRP 491
17% off